Abstract
Poly(2-oxazolines) with varying alkyl chain lengths (e.g., methyl, ethyl, aryl) and molar masses have been tested for cell cytotoxicity in vitro. A standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used for the estimation of cell viability. Two monomers, 2-methyl-2-oxazoline and 2-ethyl-2-oxazoline, were found to provide polymers with non-cytotoxic properties. The dependence of cell viability on molar mass confirmed the expected trend; the viability increased with the higher molar mass of poly(2-ethyl-2-oxazoline) (PETOX), up to 15,000 g/mol. The results obtained for the polymers with aliphatic side chains were compared with the analogues that possessed an aromatic moiety. All results confirmed low cytotoxicity of the polymers prepared by cationic polymerization of 2-alkyl- and 2-aryl-2-oxazolines, which supports their utilization in biomedical applications. Fluorescence microscopy and steady-state fluorescence were used to observe pyrene-labeled polymer interactions with living cells. Polymer accumulated within the cells was found to be dependent on polymer concentration in media. The immunoefficiency of aromatic and aliphatic oxazoline polymers and copolymers was also studied. Phagocytic and metabolic activities of macrophages were used to assess the immunosuppressive effects of the selected copolymers for possible applications in drug delivery and immunobiology. Overall, the tested polymers demonstrated no significant influences on the cellular immunological parameters.
Similar content being viewed by others
References
He C, Kim SW, Lee DS. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release. 2008;127:189–207.
Roy I, Gupta MN. Smart polymeric materials: emerging biochemical applications. Chem Biol. 2003;10:1161–71.
Jeong B, Gutowska A. Lessons from nature: stimuli responsive polymers and their biomedical applications. Trends Biotechnol. 2002;20:305–11.
Shalaby SW. Biomedical polymers: designed-to-degrade systems. Cincinnati: Hansen/Gardner Publishers; 1994.
Stuart LM, Ezekowitz RAB. Phagocytosis: elegant complexity. Immunity. 2005;22:539–50.
Gordon S. The macrophage-past, present and future. Eur J Immunol. 2007;37:S9–17.
Paulnock DM. Macrophages. New York: Oxford University Press Inc.; 2000. p. 1–209.
Adams N, Schubert US. Poly(2-oxazolines) in biological and biomedical application context. Adv Drug Deliv Rev. 2007;59:1504–20.
Kobayashi S. Ethylenimine polymers. Prog Polym Sci. 1990;15:751–823.
Litt MH, Hsieh BR, Krieger IM, Chen TT, Lu HL. Low surface energy polymers and surface-active block polymers: II. Rigid microporous foams by emulsion polymerisation. J Colloid Interface Sci. 1987;115:312–29.
Weberskirch R, Hettich R, Nuyken O, Schmaljohann D, Voit B. Synthesis of new amphiphilic star polymers derived from a hyperbranched macroinitiator by the cationic ‘grafting from’ method. Macromol Chem Phys. 1999;200:863–73.
Jin RH. Controlled location of porphyrin in aqueous micelles self-assembled from porphyrin centered amphiphilic star poly (oxazolines). Adv Mater. 2002;14:889–92.
Puts RD, Sogah DY. Universal multifunctional initiator containing orthogonal reactive sites. Synthesis of macromonomers and comb polymers using consecutive controlled free radical and cationic ring-opening polymerizations. Macromolecules. 1997;30:7050–5.
Christova D, Velichkova R, Loos W, Goethals EJ, Du Prez F. New thermo-responsive polymer materials based on poly(2-ethyl-2-oxazoline) segments. Polymer. 2003;44:2255–61.
Park JS, Akiyama Y, Winnik FM, Kataoka K. Versatile synthesis of end-functionalized thermosensitive poly(2-isopropyl-2-oxazolines). Macromoleules. 2004;37:6786–92.
Luxenhofer R, Schulz A, Roques C, Li S, Bronich TK, Batrakova EV, Jordan R, Kabanov AV. Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs. Biomaterials. 2010;31:4972–9.
Mero A, Pasut G, Dalla Via L, Fijten MWM, Schubert US, Hoogenboom R, Veronese FM. Synthesis and characterization of poly(2-ethyl-2-oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates? J Control Release. 2008;125:87–95.
Korcova J, Farkas P, Kronek J, Bystricky S. Preparation of synthetic polyoxazoline based carrier and Vibrio cholerae O-specific polysaccharide conjugate (vaccine). Eur J Med Chem. 2010;45:795–9.
Korcova J, Machova E, Farkas P, Bystricky S. Immunomodulative properties of conjugates composed of detoxified lipopolysaccharide and capsular polysaccharide of Vibrio cholerae O135 bound to BSA-protein carrier. Biologia. 2010;65:768–75.
Jeong JH, Song SH, Lim DW, Lee H, Park TG. DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline). J Control Release. 2001;73:391–9.
Lee SC, Kim C, Kwon IC, Chung H, Jeong SY. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(-caprolactone) copolymer as a carrier for paclitaxel. J Control Release. 2003;89:437–46.
Kempe K, Vollrath A, Schaefer HW, Poehlmann TG, Biskup C, Hoogenboom R, Hornig S, Schubert US. Multifunctional poly(2-oxazoline) nanoparticles for biological applications. Macromol Rapid Commun. 2010;31:1869–73.
Gaentner FC, Luxenhofer R, Blechert B, Jordan R, Essler M. Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s. J Control Release. 2007;119:291–300.
Goddard P, Hutchinson LE, Brown J, Brookman LJ. Soluble polymeric carriers for drug delivery. Part 2. Preparation and in vivo behavior of N-acylethyleneimine copolymer. J Control Release. 1989;10:5–16.
Aoi K, Okada M. Polymerization of oxazolines. Prog Polym Sci. 1996;21:151–208.
Kronek J, Luston J, Kronekova Z, Paulovicova E, Farkas P, Petrencikova N, Paulovicova L, Janigova I. Synthesis and bioimmunological efficiency of poly(2-oxazolines) containing a free amino group. J Mater Sci Mater Med. 2010;21:879–86.
Shiori T, Hamada Y, Kato S, Shibata M, Kondo Y, Nakagawa H, Kohda K. Cytotoxic activity of cyclic peptides of marine origin and their derivatives: importance of oxazoline functions. Biochem Pharm. 1987;36:4181–5.
Ross D. Metabolic basis of benzene toxicity. Eur J Haematol. 1996;57:111–8.
Klopman G, Shi LM, Ramu A. Quantitative structure–activity relationship of multidrug resistance reversal agents. Mol Pharm. 1997;52:323–34.
Acknowledgments
The authors appreciate the financial support of the Slovak Agency for the Research and Development in this Project number APVV-003206 and the Slovak Scientifical Agency VEGA in the Project nr. 2/0157/09. This work was supported in Slovak-Polish bilateral project (acronym NANOMED) nr. APVV-SK-PL-0029-09 by the Slovak Agency for the Research and Development.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kronek, J., Kroneková, Z., Lustoň, J. et al. In vitro bio-immunological and cytotoxicity studies of poly(2-oxazolines). J Mater Sci: Mater Med 22, 1725–1734 (2011). https://doi.org/10.1007/s10856-011-4346-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-011-4346-z